RxDoctor Payments Data

Arleen Revely, NP

Family · Forest Park, GANPI 1487181061

Payments from drug & device makers

$457in general payments, 2019–2025

Across 27 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$107
  • Lilly USA, LLC$91
  • Abbott$84
  • AbbVie$64
  • Bayer$57
  • Novartis$42
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$457100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk7$107
Lilly USA, LLC6$91
Abbott5$84
AbbVie3$64
Bayer3$57
Novartis2$42
GSK1$12

How this compares

$457 in reported general payments places this provider in the 50th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$2,725
Medicare patients
24
Services billed
28

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium11$26
Ibuprofen11$17

Paid to pharmacies, not to this prescriber.

Other family in Forest Park

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →